BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18534327)

  • 1. A detailed safety assessment of a saw palmetto extract.
    Avins AL; Bent S; Staccone S; Badua E; Padula A; Goldberg H; Neuhaus J; Hudes E; Shinohara K; Kane C
    Complement Ther Med; 2008 Jun; 16(3):147-54. PubMed ID: 18534327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saw palmetto for benign prostatic hyperplasia.
    Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL
    N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and toxicity of saw palmetto in the CAMUS trial.
    Avins AL; Lee JY; Meyers CM; Barry MJ;
    J Urol; 2013 Apr; 189(4):1415-20. PubMed ID: 23063633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.
    Andriole GL; McCullum-Hill C; Sandhu GS; Crawford ED; Barry MJ; Cantor A;
    J Urol; 2013 Feb; 189(2):486-92. PubMed ID: 23253958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
    J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
    Barry MJ; Meleth S; Lee JY; Kreder KJ; Avins AL; Nickel JC; Roehrborn CG; Crawford ED; Foster HE; Kaplan SA; McCullough A; Andriole GL; Naslund MJ; Williams OD; Kusek JW; Meyers CM; Betz JM; Cantor A; McVary KT;
    JAMA; 2011 Sep; 306(12):1344-51. PubMed ID: 21954478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saw palmetto for the treatment of men with lower urinary tract symptoms.
    Gerber GS
    J Urol; 2000 May; 163(5):1408-12. PubMed ID: 10751846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saw palmetto and lower urinary tract symptoms: what is the latest evidence?
    Avins AL; Bent S
    Curr Urol Rep; 2006 Jul; 7(4):260-5. PubMed ID: 16930496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serenoa repens for benign prostatic hyperplasia.
    Tacklind J; MacDonald R; Rutks I; Wilt TJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001423. PubMed ID: 19370565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
    Sudeep HV; Thomas JV; Shyamprasad K
    BMC Urol; 2020 Jul; 20(1):86. PubMed ID: 32620155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy induced by saw palmetto: a case report.
    Villanueva S; González J
    Bol Asoc Med P R; 2009; 101(3):48-50. PubMed ID: 20120986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.
    Gerber GS; Kuznetsov D; Johnson BC; Burstein JD
    Urology; 2001 Dec; 58(6):960-4; discussion 964-5. PubMed ID: 11744467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.
    Gerber GS; Zagaja GP; Bales GT; Chodak GW; Contreras BA
    Urology; 1998 Jun; 51(6):1003-7. PubMed ID: 9609640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible case of saw palmetto-induced pancreatitis.
    Wargo KA; Allman E; Ibrahim F
    South Med J; 2010 Jul; 103(7):683-5. PubMed ID: 20531057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.